Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q99PD7
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q99PD7-F1 | Predicted | AlphaFoldDB |
21 variants for Q99PD7
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs251829340 | 9 | C>R | No | EVA | |
| rs3392358480 | 31 | S>P | No | EVA | |
| rs1132196253 | 43 | R>* | No | EVA | |
| rs3388593411 | 59 | K>R | No | EVA | |
| rs3413147281 | 73 | L>V | No | EVA | |
| rs251900013 | 81 | Q>R | No | EVA | |
| rs3392368207 | 105 | R>P | No | EVA | |
| rs3392338893 | 106 | Q>L | No | EVA | |
| rs3388600887 | 135 | L>M | No | EVA | |
| rs3388600835 | 161 | P>Q | No | EVA | |
| rs3388595451 | 174 | K>E | No | EVA | |
| rs3388591425 | 243 | L>I | No | EVA | |
| rs3392341548 | 255 | K>K*VKHTACVLLTS**RYR* | No | EVA | |
| rs3388598519 | 317 | A>V | No | EVA | |
| rs3388596268 | 341 | T>I | No | EVA | |
| rs3388584037 | 344 | S>T | No | EVA | |
| rs1133186620 | 372 | I>F | No | EVA | |
| rs1133574570 | 373 | K>Q | No | EVA | |
| rs3388592828 | 392 | R>G | No | EVA | |
| rs3388589123 | 499 | M>I | No | EVA | |
| rs3388584042 | 618 | F>L | No | EVA |
No associated diseases with Q99PD7
2 regional properties for Q99PD7
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Sodium/calcium exchanger membrane region | 113 - 254 | IPR004837-1 |
| domain | Sodium/calcium exchanger membrane region | 478 - 629 | IPR004837-2 |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cell periphery | The part of a cell encompassing the cell cortex, the plasma membrane, and any external encapsulating structures. |
| integral component of plasma membrane | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| calcium channel activity | Enables the facilitated diffusion of a calcium ion (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism. |
| calcium, potassium:sodium antiporter activity | Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: Ca2+(in) + K+(in) + Na+(out) = Ca2+(out) + K+(out) + Na+(in). |
| symporter activity | Enables the active transport of a solute across a membrane by a mechanism whereby two or more species are transported together in the same direction in a tightly coupled process not directly linked to a form of energy other than chemiosmotic energy. |
8 GO annotations of biological process
| Name | Definition |
|---|---|
| bone mineralization | The deposition of hydroxyapatite, a form of calcium phosphate with the formula Ca10(PO4)6(OH)2, in bone tissue. |
| calcium ion transmembrane transport | A process in which a calcium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. |
| cation transport | The directed movement of cations, atoms or small molecules with a net positive charge, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| cellular calcium ion homeostasis | Any process involved in the maintenance of an internal steady state of calcium ions at the level of a cell. |
| negative regulation of gene expression | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
| positive regulation of gene expression | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
| potassium ion transmembrane transport | A process in which a potassium ion is transported from one side of a membrane to the other. |
| sodium ion transmembrane transport | A process in which a sodium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. |
3 homologous proteins in AiPD
| 10 | 20 | 30 | 40 | 50 | 60 |
| MPPPGDQDCA | RRRSRRRRRD | LLLSQLCFLA | SVALLLWSLS | SLREQKELDL | MDLIGEDRKW |
| 70 | 80 | 90 | 100 | 110 | 120 |
| MVGRKLMQVN | DTLTSEDAGL | QSSKNCTEPA | LHEFPRDIFS | NEDRRQGAVV | LHVLCAMYMF |
| 130 | 140 | 150 | 160 | 170 | 180 |
| YALAIVCDDF | FVPSLEKICE | RLHLSEDVAG | ATFMAAGSSA | PELFTSVIGV | FITKGDVGVG |
| 190 | 200 | 210 | 220 | 230 | 240 |
| TIVGSAVFNI | LCIIGVCGLF | AGQVVALSSW | CLLRDSIYYT | LSVVALIVFI | YDEKVSWWES |
| 250 | 260 | 270 | 280 | 290 | 300 |
| LVLVLMYLIY | IVIMKYNACI | HQCFERRTKG | AGNMVNGLAN | NAEIDDSSNC | DATVVLLKKA |
| 310 | 320 | 330 | 340 | 350 | 360 |
| NFHRKASVIM | VDELLSAYPH | QLSFSEAGLR | IMITSHFPPK | TRLSMASRML | INERQRLINS |
| 370 | 380 | 390 | 400 | 410 | 420 |
| RAYTNGESEV | AIKIPIKHTV | ENGTGPSSAP | DRGVNGTRRD | DIVAETDNET | ENENEDNENN |
| 430 | 440 | 450 | 460 | 470 | 480 |
| ENDEEEEEDE | DDDEGPYTPF | DPPSGKLETV | KWAFTWPLSF | VLYFTVPNCN | KPHWEKWFMV |
| 490 | 500 | 510 | 520 | 530 | 540 |
| TFASSTLWIA | AFSYMMVWMV | TIIGYTLGIP | DVIMGITFLA | AGTSVPDCMA | SLIVARQGMG |
| 550 | 560 | 570 | 580 | 590 | 600 |
| DMAVSNSIGS | NVFDILIGLG | LPWALQTLAV | DYGSYIRLNS | RGLIYSVGLL | LASVFVTVFG |
| 610 | 620 | 630 | 640 | ||
| VHLNKWQLDK | KLGCGCLFLY | GVFLCFSIMT | EFNVFTFVNL | PMCGD |